According to the National Center for Veterans Analysis and Statistics (2016) , there were roughly 22.3 million U.S. veterans as of 2014, almost a quarter of whom were racial or ethnic minorities. Psychiatric disorders represent the third most common condition treated in the Department of Veterans Affairs medical centers (VAMCs; U.S. Department of Veterans Affairs, 2017). Posttraumatic stress disorder (PTSD) is one of the primary mental health concerns of veterans following combat (Koenen, Stellman, Sommer, & Stellman, 2008) . African American individuals have reported higher rates of PTSD over their lives compared to their White peers (Himle, Baser, Taylor, Campbell, & Jackson, 2009) , even after controlling for sociodemographic factors, trauma history, and social support (Alegría et al., 2013) . Coleman (2016) addressed some potential explanations (e.g., transgenerational trauma and minority stress) for these mental health disparities in African American veterans with PTSD. Researchers have called for exploration of how ethnocultural variables influence symptoms of PTSD and the appropriateness of interventions (Marsella, 2010) . Further, veterans receiving care at VAMCs who show minimal symptom reduction are most likely to be male and racial-ethnic minorities (Sripada et al., 2017) . Thus, due to these health disparities for male minority veterans with PTSD, continued examination of effective treatment is warranted.
Treatment for Posttraumatic Stress Disorder
Cognitive-behavioral therapies (CBTs) are commonly used treatment methods for PTSD. Trauma-focused CBT is considered a first-line treatment for PTSD (Bisson, Roberts, Andrew, Cooper, & Lewis, 2013) . In 2006, the Department of Veterans Affairs initiated training in two evidence-based therapies-cognitive processing therapy and prolonged exposure therapy (Karlin et al., 2010 )-because both significantly reduce symptoms of PTSD in veterans (e.g., Jeffreys et al., 2014) . The use of evidencebased therapies (EBTs) for PTSD has been recommended by the Department of Veterans Affairs and the Department of Defense (2017) . However, the training, implementation, and rollout of these treatment approaches is timeintensive and requires resources. Thus, the use of alternative, cognitive-behavioral treatment approaches in real-world clinical settings is still common, and many VAMCs have also begun to utilize additional therapeutic interventions such as mindfulness training and interpersonal therapy, with promising results (Kearney, McDermott, Malte, Martinez, & Simpson, 2012; Krupnick, Melnikoff, & Reinhard, 2016) . Of relevance to the present study's aims, however, providers' ethnocentric assumptions can often lead to an inaccurate understanding of PTSD as well as inappropriate treatment approaches (Marsella, 2010) .
Group Therapy
Group therapy offers unique benefits for individuals with PTSD not possible in individual therapy. For instance, the group therapy format may decrease social isolation and avoidance of social situations, hallmarks of PTSD (Ruzek, Young, & Walser, 2003) . In treatment for PTSD, some consider the group dynamic essential for overcoming emotional detachment and numbing (symptoms fairly unique to PTSD) and for rebuilding the connection to self and others (Keenan, Lumley, & Schneider, 2014) . The group format also allows for modeling of adaptive coping strategies, group cohesion (i.e., relationship structure and quality), and development of social supports (Burlingame, McClendon, & Alonso, 2011; Burlingame, Strauss, & Joyce, 2013) . Group therapy offers the possibility of change due to factors related to provider, group, and patient characteristics (Burlingame, Fuhriman, & Mosier, 2003; Burlingame et al., 2013) .
To efficiently deal with the high demand of veteran mental health needs, a quarter of VAMCs have shifted from individual to group therapy (Tanielian & Jaycox, 2008) . Compared to other psychiatric conditions, veterans with PTSD receiving services at VAMCs are significantly more likely to receive group therapy in lieu of individual therapy, perhaps due to increasing demands for services and limited providers, cost-effectiveness, or veteran preference (Hunt & Rosenheck, 2011) . Despite the frequency with which group therapy for PTSD is used at VAMCs, it is not considered a "firstline" treatment by the Department of Veterans Affairs and Department of Defense (2017), and there is much less research examining the effectiveness of group treatment for veterans with PTSD compared to individual therapy. Additionally, although some research of adults in psychotherapy has suggested no differences between group and individual treatment in terms of dropout rates (Swift & Greenberg, 2012) , a meta-analysis of dropout for patients (veterans and civilians) with PTSD has shown increased rates for group therapy compared with individual therapy (Imel, Laska, Jakupcak, & Simpson, 2013) .
Limited research has demonstrated that various group therapies effectively reduce symptoms of PTSD for veterans (e.g., Ellis, Peterson, Bufford, & Benson, 2014; Strachan, Gros, Ruggiero, Lejuez, & Acierno, 2012; Sutherland et al., 2012) . However, other research has suggested group therapy for veterans with PTSD, although still effective, may not be as effective compared to individual therapy for reducing symptoms (Haagen, Smid, Knipscheer, & Kleber, 2015; Resick et al., 2017) . A meta-analysis found that, overall, group therapy for PTSD was better than no treatment but no better than a supportive control condition (Sloan, Feinstein, Gallagher, Beck, & Keane, 2013) . This metaanalysis also found that gender and trauma type were important moderators; thus, further work examining the effectiveness of treatment in male veteran samples is needed, as is examination of additional, potentially relevant moderators. One limitation of Sloan and colleague's (2013) study was a lack of examination of race as a moderating variable.
Despite promising evidence for the effectiveness of EBTs and group treatment modalities, it has been noted that dissemination of EBTs to clinical settings remains an ongoing effort (Foa, Gillihan, & Bryant, 2013) and that patient preference or lack of readiness may delay initiation in EBTs at the outset of treatment seeking. Further, there are notable differences between randomized-controlled trials and real-world clinical settings. Thus, there remains a need for examination of manualized group-based treatment approaches for veterans with PTSD in clinical settings. There is also a need for examination of additional moderators of treatment effectiveness that are relevant to this patient population.
Racial Differences in Treatment Access and Effectiveness
Race is a socially constructed way of grouping people based on physical characteristics (e.g., skin color, hair type, or facial features), whereas ethnicity is more closely related to an individual's culture (e.g., shared language, religious beliefs, or cuisines; Betancourt & Lopéz, 1993) . A small body of literature has demonstrated that racial minority veterans are less likely to engage in psychotherapy, in addition to being less likely to receive adequate care once engaged (Doran, Pietrzak, Hoff, & HarpazRotem, 2017) . However, minority veterans receive more sessions when enrolled in group therapy compared with individual therapy (Doran et al., 2017) . Overall, however, there is a lack of research examining differences in psychotherapy outcomes based on race for individuals with PTSD (Lester, Resick, Young-Xu, & Artz, 2010) . In a review of nearly 400 clinical trials funded by the National Institute of Mental Health, fewer than half of the studies included complete information regarding patient racial and ethnic backgrounds (Mak, Law, Alvidrez, & Pérez-Stable, 2007) . In Sloan and colleagues' (2013) meta-analysis of group treatment for PTSD, race was not assessed as a moderating variable. Extant research on treatment effectiveness for group therapy in military personnel has disregarded participants' race, either not reporting it (e.g., King et al., 2013) or not examining whether there were differences in symptom reduction after therapy based on race (Kearney et al., 2012; Morland et al., 2014; Mott et al., 2013; Ready, Vega, Worley, & Bradley, 2012; Sloan et al., 2013; Sutherland et al., 2012) . Given the dearth of research and evidence that exists regarding racial differences in PTSD, access to care, and psychotherapy session attendance, additional examination is needed to better understand the potential for racial differences in treatment outcomes for veterans with PTSD.
Current Study
The primary aim of the current study was to examine whether manualized cognitive-behavioral-based group therapy, developed for a VAMC PTSD clinic, was an effective treatment for reducing symptoms of PTSD in non-Hispanic African American and non-Hispanic White 1 male veterans with PTSD. This study focused only on one minority racial group (i.e., non-Hispanic African Americans) due to the small number of participants from other minority groups and the decision not to inappropriately assess multiple minority participants together as one group. The second aim of the study was to assess whether racial differences in effectiveness of the program existed. It was hypothesized that group therapy would effectively reduce symptoms of PTSD for both African American and White veterans, with no significant difference in treatment outcomes related to veterans' race. Furthermore, a research question as to whether the racial composition of therapy groups would also be associated with treatment outcomes (e.g., PTSD symptom reduction or session attendance) was explored.
Method

Data Source
Data were obtained from Computerized Patient Record System (CPRS; Department of Veterans Affairs Veterans Health Administration) chart review and self-report measures completed as part of program evaluation of the PTSD Recovery Program (Lynch & Mack, 2010) implemented within one PTSD clinic at a mid-Atlantic VAMC. Institutional Review Board (IRB) approval was obtained through a local university and the VAMC IRB.
Participants
Charts were initially reviewed on 515 combat veterans who were enrolled in a combat-related PTSD Recovery Program, across 50 separate groups, between 2010 and 2014 and completed a PCL-M. Because data came from an ongoing, clinical service, participants may have been involved in additional treatment (e.g., medication management); however, based on PTSD clinic protocol, participants were involved in one group at a time. For the primary study aim, the analyses focused on male group members who were either non-Hispanic White or nonHispanic African American (due to low sample sizes of women and other racial-ethnic minorities), resulting in a sample of 450. Racial demographics from the other 65 veterans were used to calculate racial-ethnic composition of each group; otherwise these participants were excluded from all analyses.
Procedure
All veterans referred to the PTSD clinic were required to attend a PTSD orientation session, after which they attend an intake session with a clinician. After intake, veterans assessed and determined as appropriate for the group received a referral to group therapy in the PTSD Recovery Program. Veterans were enrolled in an upcoming closed group based on patient preferences (e.g., time of day, day of week). Veterans enrolled in the recovery program completed self-report measures at the beginning of the first group therapy session and at the beginning of the final group session. Pre-and postdata were submitted by group therapists to one of the authors for the purpose of program evaluation. Additionally, through chart review, data were extracted from each veteran's intake session (e.g., PCL-M score, comorbid diagnosis).
The PTSD Recovery Program (Lynch & Mack, 2010 ; available free online) is a manualized, present-focused, skills-based modality that includes elements of psychoeducation, cognitive behavior therapy, in vivo exposure, stress management, acceptance and commitment therapy, mindfulness, and interpersonal effectiveness skills training. The program consists of 10 weekly group therapy sessions that last 90 min each. Each session covers a new, separate topic and requires at-home practice of skills learned. Roughly five to 14 veterans participate in each group. Typically, one or two clinicians (e.g., licensed psychologists, licensed social workers, graduate students in psychology and/or social work) facilitated each group. This program was developed at this local VAMC for veterans specifically, and although implemented primarily at this VAMC site, an updated version has been used at other VAMCs throughout the country because the manual is freely available online (see Lynch & Mack, 2010 , for the link). [OND] ), branch of service, highest enlisted rank, percentage of service connected for PTSD (financial compensation based on a disability incurred during active duty in the military), total service connection, diagnoses (e.g., mood disorder-depressive disorder, substance use disorder), and previous trauma history. Sexual orientation was unavailable from VAMC records. Data for participant diagnoses were gathered from both the active problem list (i.e., list of all current medical and mental health diagnoses) and the diagnoses listed in the medical chart for intake session to maximize inclusivity of diagnoses. To gauge participation, we calculated the number of PTSD Recovery Program group sessions attended. Group therapy dropout was calculated by determining whether veterans attended eight or more sessions, because the clinic required veterans to repeat the group therapy if they missed more than two sessions.
Measures
Group characteristics. Each therapy group was coded so that a racial-ethnic composition could be calculated. Racial composition of each group was calculated with a percentage, by using the demographic information from every individual who attended at least one session in the group. Three different group composition values were calculated: percentage of non-Hispanic Whites, percentage of nonHispanic African Americans, and percentage of racial-ethnic minorities (i.e., any racial or ethnic minority including non-Hispanic African Americans). Although racial and ethnic minorities who were not African American were excluded from primary analyses, their race and ethnicity data was used to calculate group-level variables. Groups had a relatively high composition of racial-ethnic minority veterans, with the average group composition comprising of 60% African Americans and 67% racial-ethnic minority veterans. No groups comprised less than 20% racial-ethnic minority members, nor were there any groups with 100% White veterans.
Provider characteristics. Given the nested nature of the data, provider information was assessed to determine whether providers had an influence on outcomes. A list of the providers who conducted therapy was gathered from the program evaluation data. Clinicians were asked to provide the following information (as of 2014): age, gender, ethnicity, highest degree earned, and years of clinical experience. Clinicians were explicitly told that they were not required to provide information and that any information they provided would be aggregated.
Posttraumatic Stress Disorder ChecklistMilitary Version (PCL-M; Weathers, Huska, & Keane, 1991). The PCL-M, which consists of 17 items, was the primary measure used in the study. Respondents answer the questions based on symptoms that have occurred in the last month using a 5-point Likert scale ranging from 1 (not at all) to 5 (extremely). A total score is calculated by summing scores on all items, with totals ranging from 17 to 85 (higher scores indicate more severe PTSD). PCL-M data were collected at intake, pretreatment, and posttreatment. However, for multilevel model (MLM) analyses, only pre-and posttreatment data were utilized. In addition to total scores, symptom cluster scores were also calculated. Because the PCL-M has been shown to map onto the Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-5; American Psychiatric Association, 2013; Fissette et al., 2014; Maestas, Benge, Pastorek, LeMaire, & Darrow, 2011) , the 17 items were divided into the four DSM-5 PTSD symptom clusters: reexperiencing (Items 1-5), avoidance (Items 6 -7), numbing (Items 8 -12), and hyperarousal (Items 13-17). In terms of symptom improvement, the Department of Veterans Affairs National Center for PTSD recommends a 5-point decrease in the PCL-M to indicate response to treatment, whereas a 10-point decrease is used to indicate clinically significant change. These cutoff scores are based on extant recommendations and conventional guidelines regarding use of the PCL-M in determining PTSD symptom change (Monson et al., 2008 ; U.S. Department of Veterans Affairs, National Center for PTSD, 2012). For the total sample, Cronbach's alpha at intake was .89, at pretreatment was .91, and at posttreatment was .93.
Data Analyses
Descriptive statistics and correlations were estimated using SPSS Version 22.0. Predictors of session attendance (i.e., number of sessions attended) were examined using mixed effects (i.e., multilevel) negative binomial regression in SAS Version 9.4 to account for nesting of participants within group and group within provider. Finally, normal mixed-effects models of treatment outcome (i.e., change in PTSD symptom severity) were estimated using R Version 3.2.4 (R Core Team, 2015) using the psych (Revelle, 2015) , nlme (Pinheiro, Bates, DebRoy, Sarkar, & R Core Team, 2016) , and ggplot2 (Wickham, 2009) packages. Beyond examining whether overall PTSD symptom severity decreased during the PTSD Recovery Program, mixed-effects models permitted examination of potential person-and group-level moderators of treatment efficacy (i.e., participant race) while adjusting for nesting of time within individual, individual within therapy group, and group within provider (Kahn, 2011) . Previous group therapy research has demonstrated the importance of assessing group-level and provider-level versus patient-level factors (Burlingame et al., 2013) .
Preliminary analyses were conducted to decompose the variance explained at each level of analysis. A series of MLMs were conducted to determine the best fitting model of change in PTSD symptom severity. A benefit to using MLM was that participants with missing data were included in analyses; thus, because all veterans (N ϭ 450) had either pre-or posttreatment data, they were all included in these analyses. To guide selecting the best fitting model, we computed the intraclass correlation coefficient (ICC) to identify the proportion of variance due to each level of nesting. ICCs indicated that 43.42% of the variance in PTSD symptom severity was due to variance between persons, 1.05% to variance between groups, and 3.37% to variance between providers. The remaining 52.17% of variance was due to withinsubject changes in symptoms (e.g., from pre-to posttreatment) and describes changes in symptoms over the course of treatment and measurement error. Results of the variance decomposition analysis indicated that variance in symptom levels was largely due to variability over time, over persons, and over providers. The small amount of variance between groups suggested that groups may be exchangeable regarding average symptom levels and change over treatment. For this reason, subsequent models were estimated using full information maximum likelihood to evaluate the appropriateness of removing nesting within group.
To evaluate potential moderation of treatment effectiveness, we developed a best fitting fixed-effects-only model to describe average change over time, then added random effects to evaluate potential interindividual heterogeneity in baseline symptoms and in the effectiveness of treatment (i.e., linear slope over time). Models at this stage used restricted maximum likelihood to account for the relatively small number of treatment providers (Raudenbush & Bryk, 2002) . Potential moderating variables (e.g., minority composition of groups; session attendance; and participant race, age, childhood trauma history, substance use diagnosis, and mood disorder diagnosis) were then added as main effects and cross-level moderators of participant slope (i.e., the extent to which a participant improved).
Results
Descriptive Statistics
The average age of participants in our sample (N ϭ 450) was 54.56 (SD ϭ 13.65), and the majority were African American (n ϭ 278; 61.8%) and racial-ethnic minority more broadly (66.7%). Marital status was primarily married (n ϭ 303; 67%), followed by divorced (n ϭ 75; 16.7%), never married (n ϭ 32; 7.1%), separated (n ϭ 19; 4.2%), and widowed (n ϭ 11; 2.4%). The most common education level was 12 years (n ϭ 202; 44.9%), followed by 16 years (n ϭ 123; 27.3%). Employment status was captured by three categories: disabledpensioner-retired (n ϭ 240; 53.3%), stable employment (n ϭ 144; 32.0%), and unemployed (n ϭ 44; 9.8%). Group membership ranged from three to 14 veterans (M ϭ 10.02, SD ϭ 2.35), with a modal number of nine members. Groups had a relatively high percentage of nonHispanic African American veterans (M ϭ 60.1%, SD ϭ 16.9; i.e., the average group composition was 60% African Americans). Thus, an even larger group percentage consisted of racial and ethnic minority veterans (M ϭ 66.7%, SD ϭ 17.2). The average number of sessions attended was 7.59 (SD ϭ 2.65). Among participants, 148 (32.90%) attended fewer than eight sessions, 105 (23.30%) attended fewer than seven sessions, and 74 (16.40%) attended fewer than six sessions. There was a total of 20 different providers who led or coled the groups; only 17 provided demographic data. Of those who provided data, the majority were female (n ϭ 15) and non-Hispanic White (n ϭ 15) and had an average of 11.41 (SD ϭ 8.53) years of clinical experience, and the most common degree was a doctorate of psychology (n ϭ 6). All groups had at least one provider who identified as White and was a licensed professional. The therapist with the most experience was identified as the main provider for each group, with data from a total of 11 providers used in the subsequent analyses.
Participant-reported severity of PTSD symptoms on the PCL-M decreased from pretreatment (M ϭ 63.02, SD ϭ 11.29) to posttreatment (M ϭ 55.89, SD ϭ 12.88; see Table 1 ). The symptom cluster change was as follows: reexperiencing (⌬M ϭ Ϫ1.60, SD ϭ 3.62), avoidance (⌬M ϭ Ϫ.88, SD ϭ 2.02), numbing (⌬M ϭ Ϫ2.14, SD ϭ 4.18), and hyperarousal (⌬M ϭ Ϫ2.62, SD ϭ 3.82). The average effect size for change in PTSD symptom severity from pre-to posttreatment was d ϭ .64, suggesting a medium effect (Cohen, 1988) . When examined separately by racial group, African American and White veterans, the effect sizes for the PCL-M change between pre-and posttreatment were d ϭ .63 and d ϭ .80, respectively, suggesting a medium and large effect, respectively (Cohen, 1988) .
African American and White veterans did not significantly differ on age, rank, education, employment status, marital status, service connection, PTSD symptoms at intake, therapy group size, or total number of sessions attended (ps Ͼ .18). Furthermore, participants with complete pre-and posttreatment data (n ϭ 231) and those with incomplete data (missing either pre-or posttreatment data; n ϭ 219) did not significantly differ on days between intake and starting group therapy, age, rank, education, service connection, PTSD symptom severity at intake, or therapy group size (ps Ͼ .06). There was a statistically significant association between race and childhood abuse, 2 (1, N ϭ 431) ϭ 4.49, p ϭ .03. White veterans were more likely to have reported a history of childhood abuse. 
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Session Attendance
Roughly one third (32.9%) of all participants (148 out of 450) attended fewer than eight sessions, which was deemed early termination from treatment. Univariate analyses suggested that session attendance was associated with older age (OR ϭ 1.01, 95% confidence interval [CI: 1.006, 1.011], p Ͻ .001) and lower percentage group minority composition (OR ϭ .997, 95% CI [.995, .999 ], p ϭ .01) but not with participant education, PTSD symptom severity at intake or pretreatment, group size, total service connection, provider experience, or participant race. In multivariate analysis, session attendance was associated only with older age (OR ϭ 1.01, 95% CI [1.005, 1.010], p Ͻ .001). The mixed-effects negative binomial model indicates that each 1-year increase in participant age is associated with .7% increased chance of attending one additional session.
Multilevel Model Results
Given evidence of low variance due to group membership, a model in which group membership is considered exchangeable (i.e., not modeled; Akaike's information criterion [AIC] ϭ 4,951.56) was compared against one in which participants were nested within group, which was nested within provider (AIC ϭ 4,953.34).
Comparison of these nested models with the chi-square difference test indicated that model fit did not deteriorate when removing nesting due to group, 2 (1) ϭ .23, p ϭ .63, which agreed with model selection based on lower AIC. Thus, the final model did not include nesting in groups.
On average, veterans showed a reduction of PTSD symptom severity (PCL-M scores) over time (b ϭ Ϫ6.41, 95% CI [Ϫ8.47, Ϫ4.36], p Ͻ .001; see Table 2 ). Random effects indicated substantial interindividual heterogeneity in baseline PTSD symptom severity over participants ( ϭ 10.53, 95% CI [7.27, 15.23] ) and providers ( ϭ 1.66, 95% CI [.63, 4.36] ) and heterogeneity in slope indicating that participants ( ϭ 9.03, 95% CI [3.33, 24 .47]) and providers ( ϭ 2.52, CI [1.11, 5.70]) differed from one another regarding their reduction in PTSD symptom severity.
Potential moderators were added as main effects and cross-level interaction terms to evaluate whether they were associated with baseline PTSD symptom severity or moderated improvement in PCL-M over time, respectively. Racial composition of the group, racial minority composition, session attendance, mood disorder diagnosis, race of the participants, age, childhood trauma history, and substance use disorder were not associated with change in PTSD symptom severity (ps Ͼ .18). Furthermore, race of the participants, age, substance use disorder, racial composition of the group, and racial minority composition were not associated with PTSD symptom severity at baseline (ps Ͼ .19). Presence of a mood disorder diagnosis (e.g., dysthy- 
Discussion
The present study explored the effectiveness of group therapy in the PTSD Recovery Program in reducing symptoms of PTSD in nonHispanic African American and non-Hispanic White male veterans with PTSD. Variables that potentially contributed to symptom reduction in the PTSD Recovery Program were also examined. It was predicted that the PTSD Recovery Program would reduce PTSD symptoms for both White and African American veterans, with no differences based on race. The hypothesis was supported, because results from MLM indicated that participation in this treatment was associated with a significant reduction in symptoms, for both African American and White group members. These results add to the literature on group therapy documenting the effectiveness of group therapy (Burlingame et al., 2003) , including as a treatment for reducing PTSD symptoms (Ellis et al., 2014; Sloan et al., 2013) . Results from the current study also showed that the program was effective regardless of which group veterans participated in or who provided their treatment. The finding that group-level characteristics showed the smallest variance in symptom change was somewhat contrary to previous research (Burlingame et al., 2013) ; this may be due to strong group cohesion, given that the groups consisted of combat veterans.
Statistically significant reductions in PTSD symptom severity, however, are not necessarily the same as clinically significant reductions in symptoms. Despite the statistically significant reduction in PCL-M scores during treatment, veterans on average did not show clinically significant reductions in PTSD symptom levels based on clinical guidelines (i.e., 10-point reduction in PTSD scores as measured by the PCL; Monson et al., 2008; U. S. Department of Veterans Affairs, National Center for PTSD, 2012). However, it should be noted that almost 40% of the sample with complete data reported a clinically significant reduction in symptoms, demonstrating that it was indeed effective for a notable portion of individuals who adhered to the treatment. Our moderate effect sizes were, however, in line with those found in existing studies of group psychotherapy (Burlingame et al., 2003) and group psychotherapy for PTSD (Haagen et al., 2015; Resick et al., 2017) ; these similar effects are promising, given the clinical setting and archival design of the present study.
In addition to PTSD symptom reduction, treatment attrition is another indicator of treatment effectiveness. The program defined treatment dropout as attending fewer than eight group sessions, despite our finding that the average number of group therapy sessions attended was fewer than eight. Using this metric for dropout, 32% of veterans in this study were classified as dropping out of group therapy. However, this threshold was strict compared to other definitions of dropout (fewer than six sessions: Tuerk et al., 2011 ; fewer than seven sessions: Mott et al., 2014) . These attrition rates are promising, given that at other VAMCs the average session attendance for veterans with PTSD in group therapy has been found to be fewer than five sessions (Sripada et al., 2016) . However, in comparison to the case in other research, our dropout rate was somewhat higher than what has been found in studies assessing group therapy and populations with trauma history (Sloan et al., 2013; Swift & Greenberg, 2012) .
Race of participant and racial composition of therapy groups were also examined in relation to treatment session attendance. Previous research on treatment effectiveness for group therapy in military personnel has largely ignored participants' race (King et al., 2013) or not examined differences based on race (Kearney et al., 2012; Morland et al., 2014; Mott et al., 2013; Sloan et al., 2013; Sutherland et al., 2012) . The current study found no differences in session attendance based on race of the veteran. It is possible that minority status was not predictive of therapy dropout in our sample due to the high composition of racial minority veterans in groups, a variable that was examined in the research question. Furthermore, the racial composition (i.e., percentage of African Americans in the group) and the racial-ethnic minority composition (i.e., percentage of any racial or ethnic minority in the group) were not significantly related to PTSD symptom reduction.
Racial composition of the therapy groups was not associated with the degree of reduction in PTSD symptoms for either racial group. This finding is promising, in that it implies that the program was effective for all veterans regardless the group makeup. There are a number of possible explanations for the finding that group composition did not affect PTSD symptom reduction. First, it is possible that group racial composition simply does not affect PTSD symptom reduction. Racial and ethnic minority groups in the United States may be accustomed to being a minority in various settings in which Whites are the numerical majority. Another explanation may be the population from which this sample was drawn. More specifically, the VAMC in this study had a high percentage of African American veterans as therapy clients. It is possible that, at a VAMC with a much lower percentage of racial minorities, the racial composition of the group would have a greater effect on treatment outcomes. Perhaps given the large percentage of racial minority clients in treatment for PTSD, African American veterans at this VAMC did not feel they were the "token member" of their racial group, as previous literature has suggested (Ofori-Dankwa & Julian, 2002) . Last, it is possible that groups did not hit a critical mass of minority members to demonstrate significant results (Kanter, 1977) .
Several additional results separate from the main hypotheses are important to consider. First, pretreatment PTSD symptom levels were not associated with the number of sessions veterans attended, suggesting that severity of PTSD was not associated with treatment attrition. Second, veterans with mood disorder diagnoses, compared to those without, had higher pretreatment PTSD symptom severity, although the presence of a mood disorder diagnosis was not associated with change in symptoms at posttreatment. Prior researchers have also found that veterans with comorbid PTSD and depression report high baseline rates of PTSD, but this finding may also be due to measurement issues, because the PCL-M may be assessing generalized distress (Sripada et al., 2017) .
Limitations and Future Directions
Findings should be considered in the context of a number of limitations. Because this study consisted of archival data from a program evaluation, there was no control group for comparison, and participants were not randomly selected. Similarly, given the archival nature of the study, there was no assessment of provider adherence to the program manual, a factor that has repeatedly been demonstrated to be associated with treatment improvements (Levitt, Malta, Martin, Davis, & Cloitre, 2007) and should be examined in future work. Additional measurement of PTSD symptoms at more time points would have been beneficial (e.g., midway through treatment; 6 to 12 months posttreatment). Three or more time points would have allowed for examination of trajectories of treatment response and could have supported additional causal inferences, and follow-up time points would have helped to better assess longterm symptom reduction and treatment effectiveness.
Generalizability is limited, because data were taken from a single VAMC clinic and analyses focused on a male group of participants, given the nature of the sample. Replication of findings in a more diverse heterogeneous sample is needed, because homogeneous groups demonstrate more symptom improvement (Burlingame et al., 2003) . Veterans were classified in racial groups based on their medical charts; however, participants who have been categorized as African American are not a homogeneous group (Betancourt & Lopéz, 1993) . Our study was also limited by the lack of heterogeneity of providers, which did not allow for analyses based on provider race or exploration of the interaction between provider race and group race. Another limitation was that the PCL-M was the sole measure of PTSD, so we were unable to account for treatment outcomes that would better describe the associations pertaining to the racial composition of the groups. For example, measuring a sense of social support or group cohesion and not simply PTSD symptom reduction would offer more information about the treatment as it is related to the racial composition of the group (Burlingame et al., 2011 (Burlingame et al., , 2013 . Examination of a wider array of variables relevant to both treatment outcome and moderation (e.g., therapeutic alliance, group cohesion) would be useful for expanding this research as well (Strauss, Burlingame, & Bormann, 2008) . Furthermore, there is an increased need for researchers and therapists to adhere to the American Group Psychotherapy Association (AGPA) guidelines for assessing outcomes in group therapy (Burlingame et al., 2013; Strauss et al., 2008) , because there is currently a high degree of variability in the assessment of group therapies. AGPA's guidelines include recommendations for the assessment of process measures and outcome measure. The archival nature of this study prohibited the authors from following such recommendations.
Conclusion
This study assessed the effectiveness of a 10-week group-based PTSD Recovery Program implemented in a clinical setting. Participation in the PTSD Recovery Program significantly reduced PTSD symptom severity at posttreatment for non-Hispanic African American and non-Hispanic White veterans, with no differences found based on veterans' race. Although on average the reduction in PCL-M scores were modest, improvement in this clinical sample was similar to that found in existing research on group-based therapy for veterans with PTSD (Haagen et al., 2015; Resick et al., 2017) .
